Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies

Nora Franceschini1, Daniel I Chasman, Rhonda M Cooper-DeHoff

  • 1Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 137 E. Franklin St., Suite 306, Chapel Hill, NC, USA, noraf@unc.edu.

Insights

Genetic discoveries are advancing our understanding of blood pressure regulation and hypertension. Genome-wide association studies reveal new genetic links to blood pressure variation and drug response, guiding future hypertension treatments.

Area of Science:

  • Genetics
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Hypertension is a prevalent chronic condition requiring lifelong medication.
  • Genetic factors significantly influence blood pressure levels and responses to antihypertensive drugs.

Purpose of the Study:

  • To review recent genetic discoveries related to blood pressure, hypertension, and antihypertensive drug response.
  • To highlight ancestry-specific genetic findings and their implications for drug therapy targets.

Main Methods:

  • Review of genome-wide association studies (GWAS).
  • Analysis of pharmacogenetic studies on antihypertensive drug response.
  • Inclusion of ancestry-specific findings.

Main Results:

  • GWAS have identified novel genetic loci associated with blood pressure variation and hypertension risk.
  • Pharmacogenetic studies indicate a genetic influence on blood pressure response to antihypertensive medications, though findings vary.
  • Ancestry-specific genetic variations may impact hypertension risk and drug efficacy.

Conclusions:

  • Genetic research offers insights into hypertension and its treatment.
  • Further research is needed to identify genes affecting antihypertensive medication efficacy and adverse events.
  • Understanding genetic factors can personalize hypertension management and inform novel drug target discovery.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K